The effects of the KCNQ openers retigabine and flupirtine on myotonia in mammalian skeletal muscle induced by a chloride channel blocker

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Su, Tzu Rong ^a   Zei, Wen Shan ^b   Su, Ching Chyuan ^a   Hsiao, George ^c   Lin, Min Jon ^b,d  

^a TIAN SHENG MEMORIAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

9 ANTHROIC ACID; FLUPIRTINE; LAMOTRIGINE; RETIGABINE;

ACTION POTENTIAL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INTRACELLULAR RECORDING; MOUSE; MUSCLE CONTRACTION; MUSCLE TWITCH; MYOTONIA; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TETANIC SPASM;

EID: 84859765684     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/803082     Document Type: Article

References (38)

1. Shieh C. C., Coghlan M., Sullivan J. P., Gopalakrishnan M., Potassium channels: molecular defects, diseases, and therapeutic opportunities Pharmacological Reviews 2000 52 4 557 593
2. Wu Y. J., Dworetzky S. I., Recent developments on KCNQ potassium channel openers Current Medicinal Chemistry 2005 12 4 453 460 (Pubitemid 40305631)
3. Brown D. A., Passmore G. M., Neural KCNQ (Kv7) channels British Journal of Pharmacology 2009 156 8 1185 1195
4. Wang Q., Curran M. E., Splawski I., Burn T. C., Millholland J. M., VanRaay T. J., Shen J., Timothy K. W., Vincent G. M., De Jager T., Schwartz P. J., Towbin J. A., Moss A. J., Atkinson D. L., Landes G. M., Connors T. D., Keating M. T., Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias Nature Genetics 1996 12 1 17 23 (Pubitemid 26011314)
5. Singh N. A., Charlier C., Stauffer D., DuPont B. R., Leach R. J., Melis R., Ronen G. M., Bjerre I., Quattlebaum T., Murphy J. V., McHarg M. L., Gagnon D., Rosales T. O., Peiffer A., Elving Anderson V., Leppert M., A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns Nature Genetics 1998 18 1 25 29 (Pubitemid 28027874)
6. Kubisch C., Schroeder B. C., Friedrich T., Ltjohann B., El-Amraoui A., Marlin S., Petit C., Jentsch T. J., KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness Cell 1999 96 3 437 446 (Pubitemid 29077597)
7. Robbins J., KCNQ potassium channels: physiology, pathophysiology, and pharmacology Pharmacology and Therapeutics 2001 90 1 1 19 (Pubitemid 32622837)
8. Greenwood I. A., Ohya S., New tricks for old dogs: KCNQ expression and role in smooth muscle British Journal of Pharmacology 2009 156 8 1196 1203
9. Rostock A., Tober C., Rundfeldt C., Bartsch R., Engel J., Polymeropoulos E. E., Kutscher B., Lscher W., Hnack D., White H. S., Wolf H. H., D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures Epilepsy Research 1996 23 3 211 223 (Pubitemid 26176549)
10. Blackburn-Munro G., Jensen B. S., The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain European Journal of Pharmacology 2003 460 2-3 109 116 (Pubitemid 36139977)
11. Korsgaard M. P. G., Hartz B. P., Brown W. D., Ahring P. K., Strbk D., Mirza N. R., Anxiolytic effects of maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels Journal of Pharmacology and Experimental Therapeutics 2005 314 1 282 292 (Pubitemid 41058265)
12. Roza C., Lopez-Garcia J. A., Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres Pain 2008 138 3 537 545
13. Lang P. M., Fleckenstein J., Passmore G. M., Brown D. A., Grafe P., Retigabine reduces the excitability of unmyelinated peripheral human axons Neuropharmacology 2008 54 8 1271 1278
14. Raol Y. H., Lapides D. A., Keating J. G., Brooks-Kayal A. R., Cooper E. C., A KCNQ channel opener for experimental neonatal seizures and status epilepticus Annals of Neurology 2009 65 3 326 336
15. Devulder J., Flupirtine in pain management: pharmacological properties and clinical use CNS Drugs 2010 24 10 867 881
16. Perovic S., Schleger C., Pergande G., Iskric S., Ushijima H., Rytik P., Muller W. E. G., The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-Methyl-D-aspartate and gp120 of HIV-1 European Journal of Pharmacology 1994 288 1 27 33
17. Perovic S., Pergande G., Ushijima H., Kelve M., Forrest J., Muller W. E. G., Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate Neurodegeneration 1995 4 4 369 374 (Pubitemid 26016926)
18. Rupalla K., Cao W., Krieglstein J., Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca 2+ concentration European Journal of Pharmacology 1995 294 2-3 469 473 (Pubitemid 26013239)
19. Block F., Pergande G., Schwarz M., Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats Brain Research 1997 754 1-2 279 284 (Pubitemid 27170277)
20. Seyfried J., Evert B. O., Rundfeldt C., Schulz J. B., Kovar K. A., Klockgether T., Wllner U., Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells European Journal of Pharmacology 2000 400 2-3 155 166 (Pubitemid 30438722)
21. Tsevi I., Vicente R., Grande M., Lpez-Iglesias C., Figueras A., Capell G., Condom E., Felipe A., KCNQ1/KCNE1 channels during germ-cell differentiation in the rat: expression associated with testis pathologies Journal of Cellular Physiology 2005 202 2 400 410 (Pubitemid 40041310)
22. Lerche C., Scherer C. R., Seebohm G., Derst C., Wei A. D., Busch A. E., Steinmeyer K., Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity Journal of Biological Chemistry 2000 275 29 22395 22400 (Pubitemid 30621826)
23. Schroeder B. C., Hechenberger M., Weinreich F., Kubisch C., Jentsch T. J., KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents Journal of Biological Chemistry 2000 275 31 24089 24095 (Pubitemid 30624700)
24. Roura-Ferrer M., Solé L., Martnez-Mrmol R., Villalonga N., Felipe A., Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation Biochemical and Biophysical Research Communications 2008 369 4 1094 1097
25. Iannotti F. A., Panza E., Barrese V., Viggiano D., Soldovieri M. V., Taglialatela M., Expression, localization, and pharmacological role of Kv7 potassium channels in skeletal muscle proliferation, differentiation, and survival after myotoxic insults Journal of Pharmacology and Experimental Therapeutics 2010 332 3 811 820
26. Wieland S. J., Gong Q. H., Modulation of a potassium conductance in developing skeletal muscle American Journal of Physiology 1995 268 2 C490 C495
27. Jentsch T. J., Pot M., Fuhrmann J. C., Zdebik A. A., Physiological functions of CLC Cl-channels gleaned from human genetic disease and mouse models Annual Review of Physiology 2005 67 779 807 (Pubitemid 40404510)
28. Kleopa K. A., Barchi R. L., Genetic disorders of neuromuscular ion channels Muscle and Nerve 2002 26 3 299 325 (Pubitemid 34977009)
29. Pusch M., Myotonia caused by mutations in the muscle chloride channel gene CLCN1 Human Mutation 2002 19 4 423 434 (Pubitemid 34252324)
30. Lin M. J., You T. H., Pan H., Hsiao K. M., Functional characterization of CLCN1 mutations in Taiwanese patients with myotonia congenita via heterologous expression Biochemical and Biophysical Research Communications 2006 351 4 1043 1047 (Pubitemid 44715889)
31. Cairns S. P., Ruzhynsky V., Renaud J. M., Protective role of extracellular chloride in fatigue of isolated mammalian skeletal muscle American Journal of Physiology 2004 287 3 C762 C770
32. Dutka T. L., Murphy R. M., Stephenson D. G., Lamb G. D., Chloride conductance in the transverse tubular system of rat skeletal muscle fibres: importance in excitation-contraction coupling and fatigue Journal of Physiology 2008 586 3 875 887 (Pubitemid 351194124)
33. Senges J., Rdel R., Experimental myotonia in mammalian skeletal muscle: changes in contractile properties Pflgers Archiv European Journal of Physiology 1972 331 4 315 323
34. Main M. J., Cryan J. E., Dupere J. R. B., Cox B., Clare J. J., Burbidge S. A., Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine Molecular Pharmacology 2000 58 2 253 262 (Pubitemid 30497468)
35. Rundfeldt C., Netzer R., The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits Neuroscience Letters 2000 282 1-2 73 76 (Pubitemid 30129172)
36. Wickenden A. D., Yu W., Zou A., Jegla T., Wagoner P. K., Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels Molecular Pharmacology 2000 58 3 591 600
37. Friedel H. A., Fitton A., Flupirtine: a review of its pharmacological properties and therapeutic efficacy in pain states Drugs 1993 45 4 548 569 (Pubitemid 23120130)
38. Conravey A., Santana-Gould L., Myotonia congenita and myotonic dystrophy: surveillance and management Current Treatment Options in Neurology 2010 12 1 16 28